Drug Company to Use O.C. Imaging System
- Share via
Dow Jones
ChromaVision Medical Systems Inc.’s stock surged more than 30% Thursday after the company said that ImClone Systems Inc. will use ChromaVision’s Automated Cellular Imaging System to research and develop cancer drugs.
The deal is the San Juan Capistrano company’s first significant collaboration with a drug manufacturer, analysts said.
The stock rose $1.24 a share to $5.30 in Nasdaq trading.
ImClone’s shares closed at $49.63, up $2.33, in Nasdaq trading.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
